Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock
IN
Investing.comBy Investing.com
EXECUTIVE SUMMARY
Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock....
Key Takeaways
- Opaleye Management, a 10% owner, buys $33,019 of Grace Therapeutics stock.
Read Complete Original Article
Published originally on Investing.com
